Nomura S, Eimoto T, Osawa G, Yawata Y, Horino M
Department of Medicine, Kawasaki Medical School, Okayama, Japan.
Am J Med Sci. 1991 Jul;302(1):23-7. doi: 10.1097/00000441-199107000-00006.
The lipid composition of the red cell membrane and plasma was investigated in a patient with hypothyroidism, in whom an acquired hemolytic anemia was reversed after thyroid hormone replacement therapy. Before therapy, most of the plasma lipids were elevated. In the red cell membrane, phosphatidylcholine (PC) and free cholesterol (FC) were increased, and the free cholesterol to phospholipid (FC/PL) ratio was elevated. Erythrocyte sodium transport was also increased, while intracellular sodium and potassium concentrations were normal. After therapy, the derangement of lipid levels and sodium transport activity were normalized with improvement of the hemolytic anemia. The shape of peripheral red cells also returned to normal after treatment. These findings suggest that the derangement of the red cell membrane lipids and plasma lipids derived from hypothyroidism can be a major cause of hemolysis in this patient.
对一名甲状腺功能减退患者的红细胞膜和血浆的脂质组成进行了研究,该患者在接受甲状腺激素替代治疗后,获得性溶血性贫血得到了逆转。治疗前,大多数血浆脂质升高。在红细胞膜中,磷脂酰胆碱(PC)和游离胆固醇(FC)增加,游离胆固醇与磷脂(FC/PL)的比率升高。红细胞钠转运也增加,而细胞内钠和钾浓度正常。治疗后,随着溶血性贫血的改善,脂质水平和钠转运活性的紊乱恢复正常。治疗后外周红细胞的形态也恢复正常。这些发现表明,甲状腺功能减退引起的红细胞膜脂质和血浆脂质紊乱可能是该患者溶血的主要原因。